Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease | Journal of Neurology, Neurosurgery & Psychiatry
Comparison of MOG-IgG with AQP4-IgG lesions in mouse brain | Download Table
Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis? | Neurology Neuroimmunology & Neuroinflammation
Myelin oligodendrocyte glycoprotein antibodies in neurological disease | Nature Reviews Neurology
Beyond Aquaporin and MOG- Novel brain reactive antibodies and B cell responses in Neuromyelitis optica spectrum disorders | Else Kröner-Fresenius-Stiftung
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD | HTML
E.U. paediatric MOG consortium consensus: Part 1 – Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders - ScienceDirect
Frontiers | MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder
Diagnostic implications of MOG/AQP4 antibodies in recurrent optic neuritis
Different magnetic resonance imaging features between MOG antibody- and AQP4 antibody-mediated disease: A Chinese cohort study - Journal of the Neurological Sciences
Vicente Martín on Twitter: "MOG in NMOSD Patients They have a different immunopathogenic mechanism in MOG-IgG–positive Neuromyelitis Optica Spectrum Disorders patients With some clinical, epidemiologic, and radiologic features distinct from those in
Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature - ScienceDirect
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. - Abstract - Europe PMC
Frontiers | Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
Recent developments in MOG-IgG associated neurological disorders
MRI features of MOG-IgG and AQP4-IgG seropositive patients with NMOSD | Download Table
Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood–brain barrier breakdown and peripheral plasmablasts - Multiple Sclerosis and Related Disorders
MOG antibody prevalence in adult optic neuritis and clinical predictive factors for diagnosis: a Chinese cohort study - Multiple Sclerosis and Related Disorders
Brain lesions caused by MOG-IgG and AQP4-IgG. Mice received... | Download Scientific Diagram
コラム | 岐阜大学大学院医学系研究科脳神経内科学分野
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
Pathology of myelin oligodendrocyte glycoprotein antibody–associated disease - Misu - 2021 - Clinical and Experimental Neuroimmunology - Wiley Online Library
Defining distinct features of anti-MOG antibody associated central nervous system demyelination | Semantic Scholar
Figure Model contrasting the potential role of antibodies to myelin oligodendrocyte glycoprotein (MOG) or aquaporin-4 (AQP4) in opticospinal inflammationMOG-specific. - ppt download
